Postmenopausal women are at a risk of excessive weight gain, bone loss, hypertension, and
metabolic syndrome. Obesity-induced chronic low-grade inflammation is initiated by excess
nutrients in metabolic cells. Recent studies have indicated tocotrienols (one kind of vitamin
E, a potent antioxidant) supplement may be good for mitigating negative impacts of obesity in
postmenopausal women. The purpose of the study is to examine the effect of 24-week
tocotrienols on obesity-associated outcome measurements in postmenopausal women. The
investigators will enroll 60 qualified women at the start of the study and randomly assigned
to no tocotrienols (placebo) or tocotrienols group for 24 weeks. Obesity-associated
measurements will be recorded using blood, urine, adipose tissue, and fecal samples. All data
will be analyzed statistically.